These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2002470)

  • 1. Syntheses and in vitro evaluation of water-soluble "cationic metalloporphyrin-ellipticine" molecules having a high affinity for DNA.
    Ding L; Etemad-Moghadam G; Cros S; Auclair C; Meunier B
    J Med Chem; 1991 Mar; 34(3):900-6. PubMed ID: 2002470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative cleavage of DNA mediated by hybrid metalloporphyrin-ellipticine molecules and functionalized metalloporphyrin precursors.
    Ding L; Etemad-Moghadam G; Meunier B
    Biochemistry; 1990 Aug; 29(34):7868-75. PubMed ID: 2148113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new series of ellipticine derivatives (1-(alkylamino)-9-methoxyellipticine). Synthesis, DNA binding, and biological properties.
    Larue L; Rivalle C; Muzard G; Paoletti C; Bisagni E; Paoletti J
    J Med Chem; 1988 Oct; 31(10):1951-6. PubMed ID: 3172128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ellipticine derivatives with an affinity to the estrogen receptor, an approach to develop intercalating drugs with a specific effect on the hormone-dependent breast cancer.
    Delbarre A; Oberlin R; Roques BP; Borgna JL; Rochefort H; Le Pecq JB; Jacquemin-Sablon A
    J Med Chem; 1985 Jun; 28(6):752-61. PubMed ID: 4009597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of 11H-pyridocarbazoles and derivatives. Comparison of their DNA binding and antitumor activity with those of 6H- and 7H-pyridocarbazoles.
    Lescot E; Muzard G; Markovits J; Belleney J; Roques BP; Le Pecq JB
    J Med Chem; 1986 Sep; 29(9):1731-7. PubMed ID: 3746819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Syntheses designed to produce 8-amino ellipticine. Synthesis and pharmacological properties of 8-nitro ellipticine].
    Gansser C; Lévque X; Plat M; Viel C
    Farmaco Sci; 1982 May; 37(5):283-97. PubMed ID: 7095141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential antitumor agents: synthesis and biological properties of aliphatic amino acid 9-hydroxyellipticinium derivatives.
    Auclair C; Voisin E; Banoun H; Paoletti C; Bernadou J; Meunier B
    J Med Chem; 1984 Sep; 27(9):1161-6. PubMed ID: 6471070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative degradation of cationic metalloporphyrins in the presence of nucleic acids: a way to binding constants?
    Ding L; Bernadou J; Meunier B
    Bioconjug Chem; 1991; 2(4):201-6. PubMed ID: 1772901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA intercalating compounds as potential antitumor agents. 1. Preparation and properties of 7H-pyridocarbazoles.
    Pelaprat D; Oberlin R; Le Guen I; Roques BP; Le Pecq JB
    J Med Chem; 1980 Dec; 23(12):1330-5. PubMed ID: 7452685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrelationship between affinity for DNA, cytotoxicity and induction of DNA-breaks in cultured L1210 cells for two series of tricyclic intercalators. Simplified analogues of ellipticine derivatives.
    Pierson V; Pierre A; de Cointet P; Nguyen CH; Bisagni E; Gros P
    Biochem Pharmacol; 1989 May; 38(9):1395-406. PubMed ID: 2719718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA intercalating compounds as potential antitumor agents. 2. Preparation and properties of 7H-pyridocarbazole dimers.
    Pelaprat D; Delbarre A; Le Guen I; Roques BP; Le Pecq JB
    J Med Chem; 1980 Dec; 23(12):1336-43. PubMed ID: 7452686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New dimeric analogues of ethidium; synthesis, interaction with DNA, and antitumor activity.
    Kuhlmann KF; Mosher CW
    J Med Chem; 1981 Nov; 24(11):1333-7. PubMed ID: 7310810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation and rejoining of deoxyribonucleic acid double-strand breaks induced in isolated cell nuclei by antineoplastic intercalating agents.
    Pommier Y; Schwartz RE; Kohn KW; Zwelling LA
    Biochemistry; 1984 Jul; 23(14):3194-201. PubMed ID: 6087890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ellipticine analogues and related compounds as inhibitors of reverse transcriptase and as inhibitors of the efflux pump.
    Sharples D; Hajós G; Riedl Z; Csányi D; Molnár J; Szabó D
    Arch Pharm (Weinheim); 2001 Sep; 334(8-9):269-74. PubMed ID: 11688136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclease activity and binding characteristics of a cationic "manganese porphyrin-bis(benzimidazole) dye (Hoechst 33258)" conjugate.
    Frau S; Bernadou J; Meunier B
    Bioconjug Chem; 1997; 8(2):222-31. PubMed ID: 9095364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antitumor activity of quaternary ellipticine glycosides, a series of novel and highly active antitumor agents.
    Honda T; Kato M; Inoue M; Shimamoto T; Shima K; Nakanishi T; Yoshida T; Noguchi T
    J Med Chem; 1988 Jul; 31(7):1295-305. PubMed ID: 3385725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basically substituted ellipticine analogues as potential antitumor agents.
    Werbel LM; Angelo M; Fry DW; Worth DF
    J Med Chem; 1986 Jul; 29(7):1321-2. PubMed ID: 3806584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, DNA binding, and biological activity of a series of DNA minor-groove-binding intercalating drugs.
    Bailly C; Pommery N; Houssin R; Henichart JP
    J Pharm Sci; 1989 Nov; 78(11):910-7. PubMed ID: 2621573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and cytotoxic activity of pyranocarbazole analogues of ellipticine and acronycine.
    Tran-Thi HA; Nguyen-Thi T; Michel S; Tillequin F; Koch M; Pfeiffer B; Pierré A; Trinh-Van-Dufat H
    Chem Pharm Bull (Tokyo); 2004 May; 52(5):540-5. PubMed ID: 15133204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical and pharmacological properties of the antitumor ellipticine derivative 2-(diethylamino-2-ethyl)9-hydroxy ellipticinium-chloride, HCl.
    Auclair C; Pierre A; Voisin E; Pepin O; Cros S; Colas C; Saucier JM; Verschuere B; Gros P; Paoletti C
    Cancer Res; 1987 Dec; 47(23):6254-61. PubMed ID: 3677074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.